Form 4 Aldeyra Therapeutics, For: Jun 23 Filed by: JOYCE MARTIN JOSEPH
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 8-K NEWS CORP For: Jun 24
+Rule 3.8A + See chapter 19 for defined terms 5 June 2021 Page 1 Appendix 3C Notification of buy-back Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. *Denotes minimum information required for first lodgement of this form, with exceptions provided in specific notes for certain questions. The balance of the information, where applicable,... (continue reading...)
Form 4 Aldeyra Therapeutics, For: Jun 23 Filed by: Brady Todd C
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 6-K CHINA LIFE INSURANCE CO For: Jun 27
Commission File Number 001-31914
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
June 27, 2022
China Life Insurance Company Limited
(Translation of registrant’s name into English)
16 Financial Street
Xicheng District
Beijing 100033, China
Tel: (86-10) 6363-3333
(Address of principal executive offices)
... (continue reading...)
Form SC TO-C Epizyme, Inc. Filed by: Ipsen, S.A.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE TO
TENDER OFFER STATEMENT UNDER SECTION 14(D)(1)
OR 13(E)(1) OF THE SECURITIES EXCHANGE ACT OF 1934
EPIZYME, INC.
(Name of Subject Company (Issuer))
HIBERNIA MERGER SUB, INC.
(Offeror)
a wholly owned subsidiary of
IPSEN BIOPHARMACEUTICALS, INC.
(Parent of Offeror)
a wholly owned subsidiary of
IPSEN PHARMA SAS
(Parent of Offeror)
IPSEN SA
(Other Person)
More SEC Filings
View Older Stories-
Form 6-K Burford Capital Ltd For: Jun 27
-
Form DEFA14A Spirit Airlines, Inc.
-
Form 425 Spirit Airlines, Inc. Filed by: Spirit Airlines, Inc.
-
Form 6-K CEMEX SAB DE CV For: Jun 27
-
Form 8-K Otis Worldwide Corp For: Jun 22
-
Form 8-K Spirit Airlines, Inc. For: Jun 27
-
Form S-3MEF META MATERIALS INC.
-
Form 6-K TURKCELL ILETISIM HIZMET For: Jun 27
-
Form 6-K Huize Holding Ltd For: Jun 27
-
Form 6-K NOMURA HOLDINGS INC For: Jun 27
-
Form 6-K HUTCHMED (China) Ltd For: Jun 27
-
Form F-1/A Swvl Holdings Corp
-
Form 425 Spirit Airlines, Inc. Filed by: Frontier Group Holdings, Inc.
-
Form 10-Q RDE, Inc. For: Mar 31
-
Form 25 HUANENG POWER INTERNATIO
-
Form 8-K Epizyme, Inc. For: Jun 26
-
Form 8-K Gores Guggenheim, Inc. For: Jun 23
-
Form 6-K MITSUBISHI UFJ FINANCIAL For: Jun 27
-
Form 425 Spirit Airlines, Inc. Filed by: Frontier Group Holdings, Inc.
-
Form 8-K Relay Therapeutics, Inc. For: Jun 27
-
Form 1-A POS GROUNDFLOOR REAL ESTATE
-
Form 4 Gaucho Group Holdings, For: Jun 24 Filed by: Moel Steven A.
-
Form 8-K Frontier Group Holdings, For: Jun 24
-
Form 6-K XPENG INC. For: Jun 27
-
Form 424B3 WeWork Inc.
-
Form 424B3 WeWork Inc.
-
Form 18-K/A QUEENSLAND TREASURY CORP For: Jun 30
-
Form 8-K Gores Guggenheim, Inc. For: Jun 23
-
Form 6-K EQUINOR ASA For: Jun 27
-
Form POS AM Zhong Yuan Bio-Technolog
-
Form DFAN14A Spirit Airlines, Inc. Filed by: JETBLUE AIRWAYS CORP
-
Form FWP META MATERIALS INC. Filed by: META MATERIALS INC.
-
Form DEFA14A Spirit Airlines, Inc.
-
Form 425 Silver Crest Acquisition Filed by: Silver Crest Acquisition Corp
-
Form 8-K WeWork Inc. For: Jun 23
-
Form PRE 14C Life Clips, Inc. For: Jun 27
-
Form 8-K STEPAN CO For: Jun 27
-
Form 4 Greenwich LifeSciences, For: Jun 24 Filed by: Patel Snehal
-
Form F-1/A Virax Biolabs Group Ltd
-
Form 6-K ALTERITY THERAPEUTICS For: Jun 27
-
Form 8-K Hepion Pharmaceuticals, For: Jun 24
-
Form C/A HLD Film, Inc.
-
Form 253G2 VetaNova Inc.
-
Form 8-K Silver Crest Acquisition For: Jun 27
-
Form 424B7 LiveRamp Holdings, Inc.
-
Form 6-K UNITED MICROELECTRONICS For: Jun 27
-
Form 425 Agrico Acquisition Corp. Filed by: Kalera Public Ltd Co
-
Form S-4/A Vickers Vantage Corp. I
-
Form EFFECT QUEST PATENT RESEARCH
-
Form SC 13D/A FARADAY FUTURE INTELLIGE Filed by: FF Top Holding LLC
